Argent Biopharma Ltd (RGT) — Cash Flow Reinvestment Rate

Latest as of June 2006: 0.00x

Argent Biopharma Ltd (RGT) has a Cash Flow Reinvestment Rate of 0.00x as of June 2006, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$61.70K. Check RGT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

AU$0.00
Capex + Investments

Operating Cash Flow

AU$61.70K
AUD

Capital Expenditures

AU$0.00
AUD

Argent Biopharma Ltd Cash Flow Reinvestment Rate (2006–2006)

Historical reinvestment intensity for Argent Biopharma Ltd across 1 annual periods. Explore RGT long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Argent Biopharma Ltd (2006–2006)

Year-by-year capital reinvestment analysis for Argent Biopharma Ltd. For live market cap and broader valuation context, see market cap of Argent Biopharma Ltd.

Year Reinvestment Rate Total Reinvested (AUD) Operating CF Capex YoY Change
2006 0.00x AU$0.00 AU$41.00K AU$0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow